MedPath

Acne Remission Maintenance by Weekend Systemic Isotretinoin

Phase 3
Completed
Conditions
Acne Vulgaris
Interventions
Registration Number
NCT06451237
Lead Sponsor
Alexandria University
Brief Summary

The goal of this study is to learn if isotretinoin oral tablets as a weekend regimen are safe and effective to maintain freedom from acne lesions in young adults who have completed a full course of isotretinoin on daily basis and achieved total control of the acne activity.

Detailed Description

Three groups of adult acne patients will be given a full course of isotretinoin with a cumulative dose of 120-150 mg/Kg weight in the 1st two groups, and till lesional clearance in the 3rd group with an additional month of maintenance. Afterwards, the 1st group will use adapalene gel every other day for maintenance, the 2nd and 3rd groups will use weekend oral isotretinoin. Patients will be followed for a year for reappearance of acne lesions, and safety of maintenance regimens. Patients opinion will be also sought.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Adult patients (≥ 18 years) with moderate to severe facial acne, as per the Investigator Global Assessment (IGA) scale
Exclusion Criteria
  • patients on systemic acne medications in the past 3 months or topicals in the last month, pregnant or breastfeeding females, those with evidence of endocrine disturbances or using medications for comorbidities

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Full Iso groupIsotretinoin capsulesPatients received full isotretinoin course for treatment, and maintained on weekend isotretinoin.
Adapalene groupIsotretinoin capsulesPatients received full Isotretinoin course for treatment, and maintained on every other day adapalene gel.
Clearance IsoIsotretinoin capsulesPatients treated by systemic isotretinoin till full clearance and for a month thereafter, and maintained on weekend isotretinoin.
Primary Outcome Measures
NameTimeMethod
Incidence of acne relapse during maintenance phaseone year

percent of patients having one grade worsening of their acne investigator global assessment scale achieved by end of treatment phase as assessed by the physician during follow up

Maximum severity of acne relapse during follow upOne year

Maximum investigator global assessment score reached by the the patient during the follow up year

Timing of acne relapse after initiating maintenanceone year

The time interval between initiating maintenance and the occurrence of one grade worsening of the patient's investigator global assessment scale achieved by the end of treatment phase as assessed by the physician during follow up

Incidence of adverse effectsOne year

Percent of patients reporting adverse effects in general, percent of patients reporting each category of side effects, including disturbed lipid profile, raised transaminases, psychological changes, dryness, hair shedding, ...

Secondary Outcome Measures
NameTimeMethod
Subjective convenience of maintenance regimen to patientone year

A patient oriented outcome to assess the degree of convenience of the maintenance regimen for the patient as reported on a visual analogue scale of 1-10, where 1 is the lowest convenience, and 10 is the highest convenience.

subjective patient satisfaction by maintenance regimenone year

A patient oriented outcome, in which the patients are asked by the end of maintenance year to report their degree of satisfaction by the efficacy of maintenance regimen to prevent acne relapse on a visual analogue scale of 1-10, in which 1 is lowest satisfaction and 10 is highest satisfaction.

Trial Locations

Locations (1)

Alexandria University

🇪🇬

Alexandria, Egypt

© Copyright 2025. All Rights Reserved by MedPath